MicroRNA-153 Physiologically Inhibits Expression of Amyloid-β Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients

Long, Justin M., Ray, Balmiki, Lahiri, Debomoy K.·2012·Journal of Biological Chemistry

DOI 10.1074/jbc.m112.366336

Cited by (198)

Items 101–198 of 198

Body fluid biomarkers in Alzheimer's disease.
Huan Lu, Xi‐Chen Zhu, Teng Jiang, Jin‐Tai Yu, Lan Tan · 2015 · PubMed Central
Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer’s disease and related tauopathies
Maryam Bazrgar, Pariya Khodabakhsh, Fatemeh Mohagheghi, Mercedes Prudencio, Abolhassan Ahmadiani · 2020 · Pharmacological Research
Epigenetic regulation in Alzheimer’s disease: is it a potential therapeutic target?
Fabio Coppedè · 2021 · Expert Opinion on Therapeutic Targets
Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets
J. Weldon Furr, Diego Morales‐Scheihing, Bharti Manwani, Juneyoung Lee, Louise D. McCullough · 2019 · NeuroMolecular Medicine
Epigenetic Drug Repositioning for Alzheimer’s Disease Based on Epigenetic Targets in Human Interactome
Paulami Chatterjee, Debjani Roy, Nitin Rathi · 2017 · Journal of Alzheimer s Disease
Relationship between single nucleotide polymorphisms in the 3′UTR of amyloid precursor protein and risk of Alzheimer’s disease and its mechanism
Qiong Zhou, Lian Luo, Xiaohang Wang, Xiang Li · 2019 · Bioscience Reports
Expression of miR‑28‑3p in patients with Alzheimer's disease before and after treatment and its clinical value
Xiaohua Zhao, Shan Wang, Wenbao Sun · 2020 · Experimental and Therapeutic Medicine
Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
BELKOZHAYEV AYAZ MARATOVICH, Minnatallah Al-Yozbaki, Alex George, R. Ye. Niyazova, Kamalidin O. Sharipov, Lee J. Byrne, Cornelia M. Wilson · 2021 · Current Neuropharmacology
Expression of microRNA-222 in serum of patients with Alzheimer's disease
Qinghong Zeng, Linqing Zou, Li Qian, Fang Zhou, Hongxia Nie, Shanhua Yu, Jian‐Dong Jiang, Aixia Zhuang, Chuanqi Wang, Haojiang Zhang · 2017 · Molecular Medicine Reports
Exploratory study of sport-related concussion effects on peripheral micro-RNA expression
A. Svingos, B. Asken, R. Bauer, S. Dekosky, Gabrielle A. Hromas, Michael S. Jaffee, R. Hayes, J. Clugston · 2019 · Brain Injury
Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead
Julie Lake, Catherine S. Storm, Mary B. Makarious, Sara Bandrés‐Ciga · 2021 · Cells
Non-coding RNAs and their bioengineering applications for neurological diseases
Tuhin Das, Tushar Kanti Das, Anne Khodarkovskaya, Sabyasachi Dash · 2021 · Bioengineered
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar · 2023 · Molecular Neurobiology
MicroRNA Landscape in Alzheimer’s Disease
Carlo Cogoni, Francesca Ruberti, Christian Barbato · 2015 · CNS & Neurological Disorders - Drug Targets
Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA
Kaoru Sato, Ken‐ichi Takayama, Makoto Hashimoto, Satoshi Inoue · 2021 · Frontiers in Aging
MicroRNAs and Molecular Mechanisms of Neurodegeneration
Ilaria Bicchi, Francesco Morena, Simona Montesano, Mario Polidoro, Sabata Martino · 2013 · Genes
Intravenous Immunoglobulin (IVIG) Treatment Exerts Antioxidant and Neuropreservatory Effects in Preclinical Models of Alzheimer’s Disease
Scott Counts, Balmiki Ray, Elliott Jay Mufson, Sylvia E. Perez, Bin He, Debomoy K. Lahiri · 2014 · Journal of Clinical Immunology
Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s Disease
Farida Dakterzada, Ivan David Benitez, Adriano Targa, Albert Lladó, Gerard Torres, Leila Romero, David de Gonzalo‐Calvo, Anna Moncusí‐Moix, Adrià Tort‐Merino, Raquel P Huerto et al. · 2021 · Frontiers in Aging Neuroscience
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Isidró Ferrer · 2022 · Free Neuropathology
The Potential Role of Dysregulated miRNAs in Alzheimer’s Disease Pathogenesis and Progression
Ankur A. Patel, Ganepola A.P. Ganepola, John R. Rutledge, David H. Chang · 2019 · Journal of Alzheimer s Disease
Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training
Ricardo Augusto Leoni De Sousa, Alex Cleber Improta Caria · 2022 · Metabolic Brain Disease
Targeting PSEN1 by lnc-CYP3A43-2/miR-29b-2-5p to Reduce β Amyloid Plaque Formation and Improve Cognition Function
Wei Wuli, Shinn‐Zong Lin, Shee‐Ping Chen, Bakhos A. Tannous, Wen-Sheng Huang, Peng Yeong Woon, Yang‐Chang Wu, Hsueh‐Hui Yang, Yi-Cheng Chen, Renata Lopes Fleming et al. · 2022 · International Journal of Molecular Sciences
Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells
Mythily Srinivasan, Baindu L. Bayon, Nipun Chopra, Debomoy K. Lahiri · 2016 · PLoS ONE
Advances in the Genetics and Epigenetics of Neurodegenerative Diseases
Fabio Coppedè · 2013 · Epigenetics of Degenerative Diseases
How autism and Alzheimer’s disease are TrAPPed
Debomoy K. Lahiri, Bryan Maloney, Ruizhi Wang, Deborah K. Sokol, Jack T. Rogers, Cara J. Westmark · 2020 · Molecular Psychiatry
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms?
Rebecca Piccarducci, Simona Daniele, Beatrice Polini, Sara Carpi, Lucia Chico, Jonathan Fusi, Filippo Baldacci, Gabriele Siciliano, Ubaldo Bonuccelli, Paola Nieri et al. · 2021 · Oxidative Medicine and Cellular Longevity
MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis
Marcela Alvia, Nurgül Aytan, Keith R. Spencer, Zachariah W. Foster, Nazifa Abdul Rauf, Latease Guilderson, Ian Robey, James G. Averill, Sean E. Walker, Victor E. Alvarez et al. · 2022 · Frontiers in Neuroscience
Effects of microRNA-298 on APP and BACE1 translation differ according to cell type and 3′-UTR variation
Ruizhi Wang, Debomoy K. Lahiri · 2022 · Scientific Reports
Early-life Pb exposure as a potential risk factor for Alzheimer’s disease: are there hazards for the Mexican population?
Miguel Chin-Chan, Luis Enrique Cobos-Puc, Isabel Alvarado-Cruz, Melike Bayar, Maria Ermolaeva · 2019 · JBIC Journal of Biological Inorganic Chemistry
Upregulated Blood miR-150-5p in Alzheimer’s Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy
Sook Yoong Chia, Ashwati Vipin, Kok Pin Ng, Haitao Tu, Ananth S. Bommakanti, Brian Zhiyang Wang, Yi Jayne Tan, Fatin Zahra Zailan, Adeline Su Lyn Ng, Shuo‐Chien Ling et al. · 2022 · Journal of Alzheimer s Disease
Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer’s Disease
Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2024 · Protein and Peptide Letters
Sequestration of LINE‐1 in cytosolic aggregates by MOV10 restricts retrotransposition
Rajika Arora, Maxime Bodak, Laura Penouty, Cindy Hackman, Constance Ciaudo · 2022 · EMBO Reports
Understanding the multifaceted role of miRNAs in Alzheimer’s disease pathology
Sharanjot Kaur, Harkomal Verma, Sukhchain Kaur, Prabhakar Gangwar, Anuradha Yadav, Bharti Yadav, Rashmi Rao, Monisha Dhiman, Anil Kumar Mantha · 2023 · Metabolic Brain Disease
The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer’s Disease
Samin Abed, Amir Ebrahimi, Fatemeh Fattahi, Ghazal Kouchakali, Mahmoud Shekari Khaniani, Sima Mansoori Derakhshan · 2024 · Journal of Molecular Neuroscience
RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins
Syed Arman Rabbani, Mohamed El‐Tanani, Shrestha Sharma, Yahia El‐Tanani, Rakesh Kumar, Manita Saini, Monu Yadav, Mohammad Ahmed Khan, Suhel Parvez · 2025 · European Journal of Neuroscience
Effects of Reducing Norepinephrine Levels via DSP4 Treatment on Amyloid-β Pathology in Female Rhesus Macaques (Macaca Mulatta)
Kara B. Duffy, Balmiki Ray, Debomoy K. Lahiri, Edward M. Tilmont, Gregory Paul Tinkler, Richard L. Herbert, Nigel H. Greig, Donald K. Ingram, Mary Ann Ottinger, Julie A. Mattison · 2019 · Journal of Alzheimer s Disease
Oxidative Stress and Alzheimer’s Disease
Yili Wu, Qin Xu, Weihong Song · 2014 · Springer eBooks
Neuronal microRNAs safeguard ER Ca2+ homeostasis and attenuate the unfolded protein response upon stress
Maria Paschou, Panagiota Papazafiri, Chrysanthi Charalampous, Michael Zachariadis, Skarlatos Dedos, Epaminondas Doxakis · 2022 · Cellular and Molecular Life Sciences
MicroRNA in glutamate receptor-dependent neurological diseases
Walid A. Alsharafi, Zhaohui Luo, Xiaoyan Long, Yuanyuan Xie, Bo Xiao · 2017 · Clinical Science
Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease
Yue Sun, Xinping Pang, Xudong Huang, Dinglu Liu, Jingyue Huang, Pengtao Zheng, Yanyu Wei, Chao-Yang Pang · 2024 · Neural Regeneration Research
The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target
Khojaste Rahimi Jaberi, Vahab Alamdari-Palangi, Abbas Rahimi Jaberi, Zahra Esmaili, Abolfazl Shakeri, Seyed Mohammad Gheibi Hayat, Amir Tajbakhsh, Amir Savardashtaki · 2022 · Current Molecular Medicine
Polymorphism of the OLR1 3'UTR potential microRNA binding site and risk of Alzheimer’s disease: a meta-analysis
Yan Kong, Jiakuan Wu, X. Wang, Jing Zhao, Hong‐Na Song, Liudi Yuan · 2014 · Genetics and Molecular Research
Are pulmonary fibrosis and Alzheimer's disease linked? Shared dysregulation of two miRNA species and downstream pathways accompany both disorders
Debomoy K. Lahiri, Bryan Maloney, Nigel H. Greig · 2017 · Journal of Biological Chemistry
Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Aβ pathology
Antonella Borreca, Francesco Valeri, Mariassunta De Luca, Lysianne Ernst, Arianna Russo, Annalisa Nobili, Alberto Cordella, Veronica Corsetti, Giuseppina Amadoro, Nicola Biagio Mercuri et al. · 2020 · Neurobiology of Disease
A human neuron Alzheimer’s disease model reveals barriers to senolytic translatability
Chaska C. Walton, Ellen Y. Wang, Suckwon Lee, Cynthia J. Siebrand, Nicholas J. Bergo, Zachary Mayeri, Julie Kay Andersen · 2025 · Alzheimer s Research & Therapy
Alterations of mRNAs and Non-coding RNAs Associated with Neuroinflammation in Alzheimer’s Disease
Karla Aketzalli Hernández-Contreras, Jorge Antonio Martínez-Díaz, María Elena Hernández‐Aguilar, Deissy Herrera‐Covarrubias, Fausto Rojas-Durán, Donají Chi-Castañeda, Luis I. García, Gonzálo Emiliano Aranda-Abreu · 2024 · Molecular Neurobiology
Epigenetic Modification and Its Role in Alzheimer's Disease
Yiping Zhu, Ya Feng, Te Liu, Yun‐Cheng Wu · 2015 · Integrative Medicine International
Identification and characterization of hemocyte microRNAs in mud crab Scylla paramamosain in response to Vibrio parahemolyticus infection
Qing‐Ri Jin, Guangyan Tian, Jun Wu, Hu‐Lin Jiang, Fei Zhu · 2020 · Aquaculture
Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease
Ankita Kumari, Abdul Rahaman, Xin‐An Zeng, Zulqarnain Baloch · 2024 · Molecular Therapy — Nucleic Acids
Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation
Irma A. Jiménez‐Ramírez, Enrique Castaño · 2025 · Molecular Biology Reports
Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer’s and Parkinson’s Diseases
Narmadhaa Sivagurunathan, Aghil T.S. Ambatt, Calivarathan Latchoumycandane · 2022 · Current Aging Science
An innovative biodevice towards monitoring of miR-153 using specific DNA immobilized on the surface of poly(chitosan) decorated AgNPrs/GQDs-CysA conductive nano-ink: Early-stage diagnosis of Parkinson’s disease using biosensor technology
Esmaeil Darvish Aminabad, Mohammad Hasanzadeh, Arezoo Saadati, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, Ahmad Mobed · 2022 · Materials Science and Engineering B
Effect of Vitamin E on Transcriptomic Alterations in Alzheimer’s Disease
Sophia Ogechi Ekeuku, Nuraqila Mohd Murshid, Siti Nursyazwani Shukri, Nur Fatin Nabilah Mohd Sahardi, Suzana Makpol · 2023 · International Journal of Molecular Sciences
Non-coding RNAs as key players in the neurodegenerative diseases: Multi-platform strategies and approaches for exploring the Genome’s dark matter
Hailah M. Almohaimeed, Rasha Assiri, Eman Hillal Althubaiti, Waheeb S. Aggad, Sameerah Yasain Shaheen, Marwa Y. Shaheen, Munirah A Batarfi, Nada Abdullah Alharbi, Areej Mohammed Alshehri, Basal Sulaiman M. Alkhudhairy · 2023 · Journal of Chemical Neuroanatomy
miR-153-3p suppresses the differentiation and proliferation of neural stem cells via targeting GPR55
Xiaolin Dong, Hui Wang, Liping Zhan, Qingyun Li, Li Yang, Gang Wu, Huan Wei, Yanping Li · 2023 · Aging
Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases
Xing Ge, Tingting Yao, Chaoran Zhang, Qingqing Wang, Xuxu Wang, Lichun Xu · 2022 · Current Alzheimer Research
Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes
Stylianos Ravanidis, Anastasia M. Bougea, Christos Koros, Athina‐Maria Simitsi, Panagiotis Kokotis, Leonidas Stefanis, Epaminondas Doxakis · 2025 · Molecular Neurobiology
Dysregulation of a Heme Oxygenase–Synuclein Axis in Parkinson Disease
Marisa Cressatti, Hyman M. Schipper · 2022 · NeuroSci
An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer’s disease
Sanila Amber, Saadia Zahid · 2024 · Frontiers in Genetics
A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer’s Disease
Shatakshi Mishra, Bala Kumar Stany, Anushka Das, Kanagavel Deepankumar, Murali Vijayan · 2024 · Molecular Neurobiology
Whole Transcriptome RNA-Seq Reveals Drivers of Pathological Dysfunction in a Transgenic Model of Alzheimer’s Disease
Nikita Potemkin, Sophie M. F. Cawood, Diane Guévremont, Bruce G. Mockett, Jackson M. Treece, Jo‐Ann L. Stanton, Joanna M. Williams · 2025 · Molecular Neurobiology
Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration
Ryszard M. Pluta · 2025 · Frontiers in Cellular Neuroscience
Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer’s Disease
Murali Vijayan, P. Hemachandra Reddy · 2024 · Journal of Alzheimer s Disease
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer’s Disease
Felipe Pablo Perez, Jorge Morisaki, Haitham M. Kanakri, Maher Rizkalla, Ahmed Abdalla · 2025 · IEEE Journal of Translational Engineering in Health and Medicine
Gene expression analysis reveals GRIN1, SYT1, and SYN2 as significant therapeutic targets and drug repurposing reveals lorazepam and lorediplon as potent inhibitors to manage Alzheimer’s disease
T. Premkumar, Bhavana Katta, Sajitha Lulu S, Vino Sundararajan · 2023 · Journal of Biomolecular Structure and Dynamics
Short-Term Memory Deficit Associates with miR-153-3p Upregulation in the Hippocampus of Middle-Aged Mice
Francesca Stabile, Giulia Torromino, Samyutha Rajendran, G. Del Vecchio, Carlo Presutti, Cecilia Mannironi, Elvira De Leonibus, Andrea Mele, Arianna Rinaldi · 2023 · Molecular Neurobiology
Recent Progress in the Identification of Non-Invasive Biomarkers to Support the Diagnosis of Alzheimer’s Disease in Clinical Practice and to Assist Human Clinical Trials
Francois Bernier, Pavan Kumar, Yoshiaki Sato, Yoshiya Oda · 2015 · InTech eBooks
MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease
Rui-Zhi Wang, Bryan Maloney, John S. Beck, Scott E. Counts, D. Lahiri · 2025 · Alzheimer's & Dementia
The Expanding Role of Non-Coding RNAs in Neurodegenerative Diseases: From Biomarkers to Therapeutic Targets
Xuezhi Zhao, Yixiao Zheng, Xiaoyu Tracy Cai, Yao Yao, Dongxu Qin · 2026 · Pharmaceuticals
The Ubiquitin–Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers
Rohan V. Gupta, Mohammed Yasmin Begum, Reetesh Kumar, Jyoti Gupta, Rupak Nagraik, Siva Parsad Panda, Mosleh Mohammad Abomughaid, Sorabh Lakhanpal, D Avinash, Riyaz Ali M. Osmani et al. · 2025 · Journal of Neuroimmune Pharmacology
The Human Epigenome—Implications for the Understanding of Human Disease
Manel Esteller · 2017 · Elsevier eBooks
microRNAs Mediate Signaling Pathways in Alzheimer’s Disease: Biomarkers and Therapeutic Targets
Ameneh Rezayof, Zahra Ghasemzadeh, Fatemeh Kouhkan · 2024 · Springer eBooks
Student biocuration projects as a learning environment
Kate E. Thurlow, Ruth C. Lovering, Sandra De Miranda Pinheiro · 2021 · F1000Research
Amyloid-β Protein Precursor Regulates Electrophysiological Properties in the Hippocampus via Altered Kv1.4 Expression and Function in Mice
Yi Li, Jinzhao Wang, Yueming Deng, Kun Wang, Li Yang, Cheng Long · 2023 · Journal of Alzheimer s Disease
In-depth analyses of lncRNA and circRNA expression in the hippocampus of LPS-induced AD mice by Byu d Mar 25
Yong-Cang Zhang, Liang Tang, Yan Wang, Xiao-Yan Zhu, Lan Liu · 2023 · NeuroReport
Personalized epigenetics of neurodegenerative diseases
Vipasha Gautam, Arushi Sandhu, Kajal Rawat, Anil Kumar, Lekha Saha · 2024 · Elsevier eBooks
Morpho-Functional Characterization and miRNA Profiling of the Retina in the 5xFAD Murine Model of Alzheimer's Disease
Lorenzo Guidotti, Martina Lucchesi, Eleonora Daghini, Rosario Amato, Giuseppe Neri, Francesca Corsi, Silvia Marracci, Claudia Gargini, Ugo Borello, Maurizio Cammalleri et al. · 2026 · Investigative Ophthalmology & Visual Science
Crosstalk between microRNAs and epigenetics during brain development and neurological diseases
Shalini Swaroop, Yogita K. Adlakha · 2023 · Elsevier eBooks
Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy
Sonali Sundram, Neerupma Dhiman, Rishabha Malviya, Rajendra Awasthi · 2023 · Current Gene Therapy
Epigenetics of Alzheimer’s Disease: Past, Present and Future
Divya Adiga, Sangavi Eswaran, S. Sriharikrishnaa, Nadeem Ghani Khan, Shama Prasada Kabekkodu, Dileep Kumar · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
Epigenetics of Brain Disorders
Ali Jawaid, Eloïse A. Kremer, Isabelle M. Mansuy · 2017 · Elsevier eBooks
Novel regulation of neuronal genes implicated in Alzheimer disease by microRNA
Justin M. Long · 2013 · IUScholarWorks (Indiana University)
Cognitive dysfunction in cancer: Neuroimaging and genetic approaches to identify biological mechanisms
Kelly Nicole Holohan Nudelman · 2015 · IUScholarWorks (Indiana University)
The microrna-mediated regulation of proteins implicated in the pathogenesis of Alzheimer's Disease
Nipun Chopra · 2016 · IUScholarWorks (Indiana University)
Transient upregulation of translational efficiency in prodromal Tg2576 mice precipitates AD symptoms
Antonella Borreca, Francesco Valeri, Mariassunta De Luca, Lysianne Ernst, Arianna Russo, Alberto Cordella, Veronica Corsetti, Annalisa Nobili, Giusy Amadoro, Nicola Biagio Mercuri et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
MicroRNA-Mediated Inhibition of Amyloid Beta Protein Synthesis in Alzheimer’s Disease: A Research Protocol
Katelyn R. Wang, Will Jeong, Alston Lo, Kamron M. Zaidi · 2020 · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal
Analyses of Cell Type-Specific Effects of MicroRNA-298 on Native Protein Expression Via Truncated 3’UTR Hold Translational Promise
Ruizhi Wang, Debomoy K. Lahiri · 2021 · Research Square
Sequestration of LINE-1 in novel cytosolic bodies by MOV10 restricts retrotransposition
Rajika Arora, Maxime Bodak, Laura Penouty, Cindy Hackman, Constance Ciaudo · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
MicroRNAs as Future Treatment Tools and Diagnostic Biomarkers in Alzheimer’s Disease
Heena Chauhan, Pawan Kumar Gupta, Bhagawati Saxena · 2022 · IntechOpen eBooks
Epigenetics of Brain Disorders
Ali Jawaid, Eloïse A. Kremer, Nancy V. N. Carullo, Isabelle M. Mansuy · 2022 · Elsevier eBooks
The potential role of microRNA-155 in Neurodegenerative diseases with a focus on Alzheimer's disease
Yousef Rasmi, Ameneh Shokati, Atefeh Rahimi, Shiva Gholizadeh‐Ghaleh Aziz, Yeganeh Farnamian, Amber Hassan, Shahriar Alipour · 2022 · Research Square
Editorial: Insights in RNA: 2022
Rui Li, Yadong Zheng, William Chi Shing Cho · 2024 · Frontiers in Genetics
Insights in RNA: 2022
2024 · Frontiers research topics
miR-153 promotes neural differentiation by activating the cell adhesion/Ca2+ signaling pathway and targeting ion channel activity in HT-22 cells by bioinformatic analysis
Jiao Li, Zhang Junfang, Yanna Li, Jin Caixia, Zhang Chen, Jia Song, Jie Xu, Yan Xiaoli, Xin Gui, Xing Libo et al. · 2024 · Heliyon
Suppression of miR-146a-5p/SMAD4 signaling pathway ameliorates hippocampal neuronal injury caused by chronic stress
Ruojing Guo, Ye Li, Xiao Chen, Haiyan Lou, Meijian Wang, Shu Yan Yu · 2025 · Behavioural Brain Research
Additional file 1 of Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
Longfei Jia, Zhu, Min, Yang, Jianwei, Yana Pang, Wang, Qi, Li, Ying, Li, Tingting, Li, Fangyu, Qigeng Wang, Li, Yan et al. · 2021 · Figshare
Additional file 2 of Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
Longfei Jia, Zhu, Min, Yang, Jianwei, Yana Pang, Wang, Qi, Li, Ying, Li, Tingting, Li, Fangyu, Qigeng Wang, Li, Yan et al. · 2021 · Figshare
Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease
Donepudi, Kavya, Eadha, Sreeja, Rodarte, Daniela, Sharma, Bhupender, Kumar, Subodh · 2026 · Ageing Research Reviews